Literature DB >> 21967085

The influence of psycholinguistic variables on articulatory errors in naming in progressive motor speech degeneration.

Chris Code1, Jeremy Tree, Martin Ball.   

Abstract

We describe an analysis of speech errors on a confrontation naming task in a man with progressive speech degeneration of 10-year duration from Pick's disease. C.S. had a progressive non-fluent aphasia together with a motor speech impairment and early assessment indicated some naming impairments. There was also an absence of significant phonological or semantic impairment. In order to examine naming difficulties and the factors that influence his speech production errors, we selected 210 words varying in frequency, age of acquisition (AoA), imageability, phonemic length and syllable length and conducted a logistic regression analysis on a range of speech production error types (phone omissions, additions, substitutions, response delays, overall errors). No significant naming errors due to lexical access were found. The only significant predictor of speech articulation errors was phonemic length, with none of the other lexical variables influencing speech production error. The only error type predicted was phone omissions. Results suggest that C.S.'s speech and naming errors indicate compromised speech programming/planning rather than lexical selection and we conclude that this pattern of findings is indicative of problems with motor speech production.

Entities:  

Mesh:

Year:  2011        PMID: 21967085     DOI: 10.3109/02699206.2011.601390

Source DB:  PubMed          Journal:  Clin Linguist Phon        ISSN: 0269-9206            Impact factor:   1.346


  1 in total

1.  Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.

Authors:  Jolien Schaeverbeke; Silvy Gabel; Karen Meersmans; Rose Bruffaerts; Antonietta Gabriella Liuzzi; Charlotte Evenepoel; Eva Dries; Karen Van Bouwel; Anne Sieben; Yolande Pijnenburg; Ronald Peeters; Guy Bormans; Koen Van Laere; Michel Koole; Patrick Dupont; Rik Vandenberghe
Journal:  Alzheimers Res Ther       Date:  2018-07-18       Impact factor: 6.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.